Alban Longchamp, Ph.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hydrogen Sulfide | 11 | 2022 | 142 | 2.550 |
Why?
|
Tunica Intima | 6 | 2021 | 482 | 1.830 |
Why?
|
Reperfusion Injury | 5 | 2021 | 1067 | 1.120 |
Why?
|
Hyperplasia | 6 | 2022 | 1167 | 0.870 |
Why?
|
Activating Transcription Factor 4 | 2 | 2022 | 83 | 0.870 |
Why?
|
Saphenous Vein | 3 | 2018 | 512 | 0.850 |
Why?
|
Veins | 5 | 2021 | 745 | 0.820 |
Why?
|
Warm Ischemia | 1 | 2019 | 51 | 0.760 |
Why?
|
Aneurysm, False | 1 | 2022 | 281 | 0.750 |
Why?
|
Amino Acids, Sulfur | 1 | 2018 | 19 | 0.690 |
Why?
|
Kidney Transplantation | 4 | 2021 | 4140 | 0.690 |
Why?
|
Diet, Protein-Restricted | 4 | 2020 | 78 | 0.650 |
Why?
|
Aortic Aneurysm | 1 | 2022 | 663 | 0.650 |
Why?
|
Vascular Grafting | 2 | 2019 | 159 | 0.640 |
Why?
|
Perfusion | 3 | 2020 | 1269 | 0.630 |
Why?
|
Hypothermia, Induced | 1 | 2019 | 719 | 0.530 |
Why?
|
Connexin 43 | 1 | 2015 | 216 | 0.520 |
Why?
|
Hydrogels | 1 | 2019 | 628 | 0.520 |
Why?
|
Adenosine Triphosphate | 1 | 2020 | 2023 | 0.500 |
Why?
|
Cystathionine gamma-Lyase | 5 | 2022 | 34 | 0.490 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2022 | 1309 | 0.470 |
Why?
|
Preoperative Care | 3 | 2018 | 2344 | 0.420 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2022 | 3687 | 0.410 |
Why?
|
Fasting | 1 | 2017 | 1594 | 0.390 |
Why?
|
Kidney | 4 | 2020 | 6881 | 0.380 |
Why?
|
Endovascular Procedures | 1 | 2022 | 1925 | 0.360 |
Why?
|
Critical Illness | 2 | 2020 | 2529 | 0.340 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2018 | 3493 | 0.320 |
Why?
|
Peptides | 1 | 2019 | 4384 | 0.310 |
Why?
|
Caloric Restriction | 4 | 2022 | 346 | 0.300 |
Why?
|
Tissue Scaffolds | 1 | 2014 | 921 | 0.300 |
Why?
|
Carotid Stenosis | 3 | 2021 | 812 | 0.300 |
Why?
|
Graft Occlusion, Vascular | 3 | 2020 | 527 | 0.290 |
Why?
|
Ischemia | 3 | 2019 | 1906 | 0.280 |
Why?
|
Swine | 4 | 2022 | 5802 | 0.240 |
Why?
|
Methionine | 3 | 2022 | 611 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3163 | 0.220 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3280 | 0.210 |
Why?
|
Glycerol | 1 | 2022 | 264 | 0.210 |
Why?
|
Phosphorus | 1 | 2022 | 341 | 0.210 |
Why?
|
Captopril | 1 | 2021 | 272 | 0.210 |
Why?
|
Myocytes, Smooth Muscle | 4 | 2022 | 717 | 0.200 |
Why?
|
Hemorrhoids | 1 | 2020 | 20 | 0.200 |
Why?
|
Pandemics | 1 | 2020 | 7311 | 0.200 |
Why?
|
Abdominal Cavity | 1 | 2019 | 33 | 0.190 |
Why?
|
Transplants | 1 | 2022 | 206 | 0.190 |
Why?
|
Animals | 22 | 2022 | 169420 | 0.190 |
Why?
|
Malaria, Cerebral | 1 | 2021 | 127 | 0.190 |
Why?
|
Adiponectin | 2 | 2016 | 1089 | 0.180 |
Why?
|
Versicans | 1 | 2018 | 32 | 0.180 |
Why?
|
Parasites | 1 | 2021 | 134 | 0.180 |
Why?
|
Niacinamide | 1 | 2021 | 428 | 0.170 |
Why?
|
Sirtuin 1 | 2 | 2018 | 303 | 0.170 |
Why?
|
Neointima | 2 | 2020 | 144 | 0.170 |
Why?
|
Urine | 1 | 2019 | 381 | 0.170 |
Why?
|
Reperfusion | 1 | 2019 | 292 | 0.160 |
Why?
|
Lipoproteins, VLDL | 1 | 2018 | 226 | 0.160 |
Why?
|
Physical Conditioning, Animal | 2 | 2018 | 364 | 0.160 |
Why?
|
Vena Cava, Inferior | 1 | 2020 | 437 | 0.150 |
Why?
|
Body Temperature | 1 | 2019 | 790 | 0.150 |
Why?
|
Antibody Formation | 1 | 2020 | 1420 | 0.140 |
Why?
|
Tissue Donors | 2 | 2022 | 2151 | 0.140 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2019 | 567 | 0.140 |
Why?
|
Liver | 5 | 2022 | 7594 | 0.140 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2022 | 857 | 0.140 |
Why?
|
Surgical Wound Dehiscence | 1 | 2016 | 214 | 0.130 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2017 | 373 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1482 | 0.130 |
Why?
|
Cryopreservation | 1 | 2019 | 631 | 0.130 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18199 | 0.130 |
Why?
|
Postoperative Period | 1 | 2019 | 1843 | 0.130 |
Why?
|
Aorta | 1 | 2022 | 2074 | 0.130 |
Why?
|
Radiation Injuries | 1 | 2022 | 1224 | 0.130 |
Why?
|
Longevity | 1 | 2022 | 1030 | 0.130 |
Why?
|
Ephrin-B2 | 1 | 2014 | 42 | 0.130 |
Why?
|
Receptor, EphB4 | 1 | 2014 | 33 | 0.130 |
Why?
|
Arteries | 1 | 2019 | 1084 | 0.130 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 620 | 0.130 |
Why?
|
NAD | 1 | 2018 | 616 | 0.120 |
Why?
|
Lower Extremity | 2 | 2019 | 1043 | 0.120 |
Why?
|
Muscle Contraction | 1 | 2019 | 1240 | 0.120 |
Why?
|
Neovascularization, Physiologic | 2 | 2018 | 1403 | 0.120 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2014 | 168 | 0.120 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2017 | 619 | 0.120 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2017 | 662 | 0.120 |
Why?
|
Polyesters | 1 | 2014 | 368 | 0.120 |
Why?
|
Models, Animal | 1 | 2019 | 2204 | 0.110 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2014 | 295 | 0.110 |
Why?
|
Surgical Mesh | 1 | 2014 | 249 | 0.110 |
Why?
|
RNA Interference | 2 | 2018 | 2985 | 0.110 |
Why?
|
Mice, Inbred C57BL | 6 | 2022 | 22665 | 0.110 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2014 | 248 | 0.110 |
Why?
|
Stress, Physiological | 2 | 2017 | 1426 | 0.110 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3574 | 0.110 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2014 | 480 | 0.110 |
Why?
|
Dietary Carbohydrates | 1 | 2017 | 913 | 0.100 |
Why?
|
Caspase 3 | 1 | 2014 | 796 | 0.100 |
Why?
|
Subcutaneous Fat | 1 | 2014 | 385 | 0.100 |
Why?
|
Artificial Intelligence | 1 | 2022 | 1744 | 0.100 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 712 | 0.100 |
Why?
|
Stents | 1 | 2022 | 3207 | 0.100 |
Why?
|
Pressure | 1 | 2014 | 1234 | 0.100 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2014 | 685 | 0.100 |
Why?
|
Humans | 24 | 2022 | 715777 | 0.100 |
Why?
|
Endarterectomy, Carotid | 1 | 2015 | 527 | 0.100 |
Why?
|
Glucose | 1 | 2022 | 4273 | 0.100 |
Why?
|
Triglycerides | 1 | 2018 | 2577 | 0.100 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 1162 | 0.090 |
Why?
|
Hyperglycemia | 1 | 2018 | 1356 | 0.090 |
Why?
|
Mice | 10 | 2022 | 80375 | 0.090 |
Why?
|
Rabbits | 1 | 2015 | 5061 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2015 | 1571 | 0.090 |
Why?
|
Stress, Mechanical | 1 | 2014 | 1685 | 0.090 |
Why?
|
Aging | 2 | 2018 | 8350 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1886 | 0.080 |
Why?
|
Graft Rejection | 1 | 2021 | 4396 | 0.080 |
Why?
|
Wound Healing | 1 | 2018 | 2778 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 1985 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2096 | 0.080 |
Why?
|
Vascular Patency | 2 | 2020 | 841 | 0.080 |
Why?
|
Vascular Surgical Procedures | 1 | 2016 | 1451 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2016 | 1498 | 0.070 |
Why?
|
Animals, Genetically Modified | 2 | 2022 | 1582 | 0.070 |
Why?
|
Down-Regulation | 1 | 2014 | 3066 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1974 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1113 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2014 | 1744 | 0.070 |
Why?
|
Male | 15 | 2022 | 350324 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2022 | 10620 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2022 | 2425 | 0.060 |
Why?
|
Rats | 1 | 2019 | 24860 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8270 | 0.050 |
Why?
|
Thiosulfates | 1 | 2022 | 58 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2020 | 15059 | 0.050 |
Why?
|
Insulin | 1 | 2017 | 6651 | 0.050 |
Why?
|
Gluconeogenesis | 1 | 2022 | 186 | 0.050 |
Why?
|
Radiation, Ionizing | 1 | 2022 | 275 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2022 | 62004 | 0.050 |
Why?
|
Pyridinium Compounds | 1 | 2021 | 82 | 0.050 |
Why?
|
Female | 10 | 2020 | 377204 | 0.050 |
Why?
|
Aspartic Acid | 1 | 2022 | 579 | 0.050 |
Why?
|
Caenorhabditis elegans | 2 | 2022 | 1410 | 0.050 |
Why?
|
Primates | 1 | 2022 | 513 | 0.050 |
Why?
|
Cholesterol, Dietary | 1 | 2020 | 236 | 0.050 |
Why?
|
Enzyme Induction | 1 | 2020 | 496 | 0.050 |
Why?
|
Organ Culture Techniques | 1 | 2021 | 856 | 0.040 |
Why?
|
Vasa Vasorum | 1 | 2018 | 29 | 0.040 |
Why?
|
Carotid Artery, Common | 1 | 2020 | 186 | 0.040 |
Why?
|
Serine | 1 | 2022 | 827 | 0.040 |
Why?
|
Tunica Media | 1 | 2018 | 117 | 0.040 |
Why?
|
Tubulin | 1 | 2022 | 759 | 0.040 |
Why?
|
Dextrothyroxine | 1 | 2017 | 6 | 0.040 |
Why?
|
Hydrolysis | 1 | 2018 | 684 | 0.040 |
Why?
|
Tissue Culture Techniques | 1 | 2018 | 293 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2020 | 522 | 0.040 |
Why?
|
Dietary Proteins | 1 | 2022 | 958 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2021 | 938 | 0.040 |
Why?
|
Glutamic Acid | 1 | 2022 | 1155 | 0.040 |
Why?
|
Limb Salvage | 1 | 2019 | 423 | 0.040 |
Why?
|
Adipose Tissue | 2 | 2021 | 3225 | 0.040 |
Why?
|
Diet | 1 | 2014 | 7565 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2018 | 664 | 0.040 |
Why?
|
Apolipoproteins | 1 | 2018 | 310 | 0.040 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 539 | 0.040 |
Why?
|
Hypertriglyceridemia | 1 | 2018 | 293 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58323 | 0.030 |
Why?
|
Ultrasonography, Doppler, Pulsed | 1 | 2014 | 22 | 0.030 |
Why?
|
Time Factors | 4 | 2020 | 40875 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 2018 | 498 | 0.030 |
Why?
|
Growth Hormone | 1 | 2017 | 693 | 0.030 |
Why?
|
Cisplatin | 1 | 2021 | 1654 | 0.030 |
Why?
|
Amputation | 1 | 2019 | 763 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 19910 | 0.030 |
Why?
|
Yeasts | 1 | 2014 | 290 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2015 | 278 | 0.030 |
Why?
|
Microvessels | 1 | 2018 | 553 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2014 | 666 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2018 | 754 | 0.030 |
Why?
|
Leptin | 1 | 2021 | 1573 | 0.030 |
Why?
|
Stroke | 1 | 2015 | 9505 | 0.030 |
Why?
|
Aged | 5 | 2019 | 162448 | 0.030 |
Why?
|
Urea | 1 | 2014 | 441 | 0.030 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2014 | 337 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1207 | 0.030 |
Why?
|
Bone Marrow | 1 | 2022 | 2926 | 0.030 |
Why?
|
Nutritional Status | 1 | 2020 | 1544 | 0.030 |
Why?
|
Graft Survival | 1 | 2021 | 3750 | 0.030 |
Why?
|
Signal Transduction | 3 | 2022 | 23729 | 0.020 |
Why?
|
Middle Aged | 5 | 2019 | 214639 | 0.020 |
Why?
|
Cysteine | 1 | 2014 | 872 | 0.020 |
Why?
|
Risk Factors | 4 | 2019 | 70866 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1990 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3110 | 0.020 |
Why?
|
Reoperation | 1 | 2019 | 4169 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 2028 | 0.020 |
Why?
|
Creatinine | 1 | 2014 | 1898 | 0.020 |
Why?
|
Biological Evolution | 1 | 2014 | 1084 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2677 | 0.020 |
Why?
|
Life Expectancy | 1 | 2014 | 1143 | 0.020 |
Why?
|
Energy Intake | 1 | 2014 | 2153 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8544 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2014 | 1756 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2018 | 3374 | 0.020 |
Why?
|
Stem Cells | 1 | 2018 | 3569 | 0.020 |
Why?
|
Mitochondria | 1 | 2018 | 3613 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11689 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19537 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2015 | 1358 | 0.020 |
Why?
|
Hemodynamics | 1 | 2014 | 4214 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13215 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4931 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 72443 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9596 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15909 | 0.010 |
Why?
|
Prospective Studies | 2 | 2015 | 51315 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13626 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16311 | 0.010 |
Why?
|
United States | 1 | 2022 | 67905 | 0.010 |
Why?
|
Child | 1 | 2021 | 74468 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 40029 | 0.010 |
Why?
|
Adult | 1 | 2019 | 212266 | 0.000 |
Why?
|